- On 21 August 2026, AutyFIT Editorial reviewed bakuchiol and asked for clearer labels around sensitive skin.
- The core 2019 trial tested 0.5% bakuchiol used twice daily against 0.5% retinol used once daily across 12 weeks in 44 people.
- Wrinkle area and dark spots improved in both arms, while scaling and stinging were reported more often with retinol.
On 21 August 2026 AutyFIT Editorial issued an evidence review that revisited bakuchiol as a plant rooted option beside retinol. The review placed a 12 week head to head trial from 2019 at its center and asked for clearer claims on labels and shelves.
For readers who keep babchi on the shelf in another form, the update is modest and practical. The most direct comparison showed similar change in visible photoageing with gentler tolerance for bakuchiol. That finding belongs to a single tested routine. That does not make every bakuchiol serum equal to retinol.
The remedy begins in the field with the source plant. Bakuchiol is a meroterpene phenol linked to the seeds and leaves of Psoralea corylifolia, named Cullen corylifolium in some references. A seed oil and a low level extract and high purity bakuchiol remain very different starting materials. The 2020 Pierre Fabre study reported its bakuchiol raw material as approximately 95 percent pure.
The human trial was tight in scope and detail. It was recorded on ClinicalTrials.gov as NCT03112863. It compared 0.5 percent bakuchiol used twice daily with 0.5 percent retinol used once daily for 12 weeks in 44 participants. Both groups showed significant falls in wrinkle surface area and hyperpigmentation, with no statistical gap between compounds on those measures. One summary described the change as 20 to 30 percent drops in fine lines and hyperpigmentation.
Comfort set the two routines apart. People using retinol reported more facial scaling and stinging than people using bakuchiol. In 2019 Chaudhuri and Bojanowski wrote in the British Journal of Dermatology that their study shows bakuchiol matches retinol for improving photoageing and is better tolerated than retinol.
The plant chemistry gives context for the attention without pushing past the data. Retinol turns into retinoic acid in skin and engages retinoid receptors, while bakuchiol does not turn into retinoic acid. Gene expression work from 2014 found bakuchiol switched on downstream collagen supporting pathways while calming MMPs that wear down collagen. Later summaries point toward that same result. A review in the Journal of Integrative Dermatology searched PubMed and EMBASE for bakuchiol and photoaging, kept seven articles from 2014 to 2021, and found bakuchiol matched retinol for efficacy with better tolerability when tested side by side. A 2024 comparative study in the Journal of Cosmetic Dermatology reported matching results for photoaging and hyperpigmentation after 12 weeks with fewer notes of redness and scaling.
What comes next turns on harvest and amount. The head to head set different regimens, so it weighed routines rather than gram for gram strength. Product language often folds cell and animal and human findings into one studies show claim, which reaches past what cosmetic trials measured. A market analysis by Grand View Research in 2025 tipped the global bakuchiol market to grow at a compound annual growth rate of 7.5 percent through 2030, which may bring more formulas with less clarity.
For now, keep bakuchiol as one tended row in the garden for reactive routines, not a full replacement for each retinoid outcome.
Kathryn Foster
Kathryn runs the news desk and the remedy guides at Root to Bottle. She keeps a shelf of old herbals at her desk and checks every traditional use against what the trials actually found, then writes down both.
More from Kathryn Foster →
